Tech Company Financing Transactions

Korro Bio Funding Round

Eventide Asset Management, Alexandria Venture Investments and Atlas Venture invested in a $116 million Series B funding round for Korro Bio. The financing closed on 1/7/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

400 Technology Sq. 10th Floor
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.korrobio.com

Email Address

[email protected]

Overview

At Korro Bio our aim is to bring transformative treatments to patients with rare and debilitating diseases by addressing the underlying genetic cause. We are utilizing the precision provided by nucleic acid-based therapeutics to target the sequences responsible within the genetic code.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Nessan Bermingham

        

Founder

Jean Formela

        

Founder

Joshua Rosenthal

        

Vice President

Matthew Jarpe

        

Vice President

Stuart Milstein

        

VP - Bus. Development

Yong Chang

        

VP - Engineering

Andrew Fraley

        

VP - General Counsel

Anna Barry

        

Browse more venture capital transactions:

Prev: 1/7/2022: headversity venture capital transaction
Next: 1/7/2022: Carsome venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary